Stem Cell Therapy Cost Abroad, and How to Check the Licence

Price lists for stem cell treatment abroad are easy to find. The medical-travel agency Bookimed quotes $1,600 to $9,500 in Mexico, against $8,100 to $12,700 in the US.¹ A 2026 study of Panama found clinics charging $5,000 to $50,000.²

What those pages rarely show is whether the clinic holds the licence its own country requires. This article sets the quoted prices beside the rules in Mexico, Panama and Japan, and shows which of them a patient can check.

Prices and licence checks at a glance

LowHigh

Mexico (Bookimed)$1,600 / $9,500

Mexico (Medical Tourism Magazine)$3,500 / $15,000

US (Bookimed)$8,100 / $12,700

Panama (2026 study)$5,000 / $50,000

Seller and researcher quotes in US dollars, not audited charges; ranges cover different treatments and conditions. Panama range from a 2026 Stem Cell Reports study as reported by La Prensa; second Mexico range from Medical Tourism Magazine.

Source: note 1

Show the numbers

Item	Low	High
Mexico (Bookimed)	$1,600	$9,500
Mexico (Medical Tourism Magazine)	$3,500	$15,000
US (Bookimed)	$8,100	$12,700
Panama (2026 study)	$5,000	$50,000

The bars are quotes from sellers and researchers, not audited charges. They do not describe the same treatment, number of injections or condition. Japan is left off the chart: its one published example, from Nature in 2019, was ¥1.5 million a dose.³

Mexico: a licence exists, but no public register was found

Mexico's General Health Law lists the facilities that need a health licence. The list includes "la disposición de células troncales", the use of stem cells, and "los establecimientos de medicina regenerativa", regenerative medicine facilities.⁴

So a clinic injecting stem cells in Mexico needs that licence. We searched the websites of the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) and the National Transplant Centre. We found no public register where a patient can look up a clinic's licence by name.

Prices disagree too. Bookimed puts Mexico at $1,600 to $9,500.¹ Medical Tourism Magazine quotes $3,500 to $7,000 for joint treatment and $8,000 to $15,000 for neurological conditions.⁵ It puts multi-day protocols at $15,000 to $30,000 or more.⁵ Both publishers earn from medical travel. The gap comes from what each counts: one gives a single band, the other prices by condition.

Panama: four authorised centres, six companies selling

Panama's Executive Decree 179 of June 2018 sets the rules for therapy with human cells.⁶ According to La Prensa's reading of it, blood stem cell transplants are the only use with proven evidence.⁶ Four institutions are authorised for them: the Instituto Oncológico Nacional, the Complejo Hospitalario Dr. Arnulfo Arias Madrid, the Hospital del Niño and The Panama Clinic.⁶

Any other use must run as research approved by the National Bioethics Research Committee and the Ministry of Health.⁶

Researchers from the Gorgas Memorial Institute and the national bioethics committee published a study in Stem Cell Reports in July 2026. As reported by La Prensa, they found at least six companies selling stem cell treatments in Panama by late 2025.² Prices ran from $5,000 to $50,000, for conditions including spinal injury, autism and multiple sclerosis.² The newspaper reports that no commercial clinic had filed a research protocol since 2018.²

One clinic's own prices sit inside that range. In 2021, stem cell researcher Paul Knoepfler quoted the Stem Cell Institute's website at $15,825 for children and $23,150 for adults.⁷

Enforcement has started. On 31 August 2026, La Prensa reported that the Ministry of Health had inspected two stem cell businesses. It opened administrative cases over missing operating permits and unregistered products.⁸ As of that report, no sanction had been announced.

Japan: every plan is public, which is not the same as proven

Japan took the opposite route. Its Act on the Safety of Regenerative Medicine took effect in November 2014. A clinic must have each treatment plan reviewed by a certified committee and filed with the Ministry of Health, Labour and Welfare.³⁹ The ministry publishes the plans on its e-Regenerative Medicine site, sorted by risk class.¹⁰

By February 2022 there were 3,534 lower-risk and 1,040 medium-risk therapy plans on file.⁹ The same study found that 51.9% of the clinic websites it checked used promotional language the rules ban.⁹

The law checks safety procedures, not results. Nature reported in 2019 that it lets clinics sell cell therapies without trials proving they work.³ One Tokyo clinic quoted ¥1.5 million a dose for a treatment for the nerve disease ALS (amyotrophic lateral sclerosis).³ Doug Sipp, a regulatory researcher at RIKEN, warned that patients may read the registry "as a kind of validation".³

What the headline numbers leave out

A US comparison price is not a US approved treatment. The US Food and Drug Administration (FDA) last updated its consumer alert in April 2024. It said the only approved stem cell products were blood-forming cells from umbilical cord blood, for blood disorders.¹¹ In December 2024 the FDA added Ryoncil, a stem cell product for children with a complication of bone marrow transplants.¹² Treatments for joints, autism or anti-ageing are not on that list.¹¹

The price may not be the whole course. Knoepfler noted that costs rise with repeat injections and return trips.⁷ Japan's ALS example was a per-dose price, with infusions advised every two or three months.³

A licence is a minimum. In Panama and Japan, the rules separate a proven use from research. Ask which one you are being sold.

How to check a clinic before you pay

• Mexico: ask for the licence document itself, and check that it names stem cells or regenerative medicine. Keep a copy with your contract.
• Panama: ask whether the treatment is a blood stem cell transplant at one of the four centres. If not, ask for the research protocol approval.
• Japan: ask for the plan number, then find the plan on the ministry's site. Read what condition it is filed for.

If a clinic will not give you any of these, treat the price as unverified. Read the deposit terms before you send money, too: see our guide to non-refundable deposits at clinics abroad.

Footnotes

1. https://us-uk.bookimed.com/article/stem-cell-therapy-cost/ — Bookimed, "Stem cell therapy cost" (updated Oct 2026). Accessed Oct 16, 2026. ↩ ↩²

2. https://www.prensa.com/sociedad/celulas-madre-en-panama-clinicas-ofrecen-tratamientos-sin-evidencia-cientifica/ — La Prensa (Panama), "Células madre en Panamá: clínicas ofrecen tratamientos sin evidencia científica" (published Jul 24, 2026), reporting a study by Solís, Quintana, Candanedo and others in Stem Cell Reports (Jul 23, 2026). Accessed Oct 16, 2026. ↩ ↩² ↩³ ↩⁴

3. https://media.nature.com/original/magazine-assets/d41586-019-02847-3/d41586-019-02847-3.pdf — David Cyranoski, Nature, "Stem cells 2 go", vol. 573 (published Sep 26, 2019). Accessed Oct 16, 2026. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

4. https://mley.mx/LGS/articulo/315/ — Ley General de Salud (Mexico), Article 315, as reproduced by mley.mx. Accessed Oct 16, 2026. ↩

5. https://www.magazine.medicaltourism.com/article/what-does-stem-cell-therapy-cost-in-mexico-2025-pricing-guide — Medical Tourism Magazine, "What Does Stem Cell Therapy Cost in Mexico? 2025 Pricing Guide" (published 2025). Accessed Oct 16, 2026. ↩ ↩²

6. https://www.prensa.com/sociedad/celulas-madre-en-panama-estos-son-los-cuatro-centros-autorizados-para-su-uso/ — La Prensa (Panama), "Células madre en Panamá: estos son los cuatro centros autorizados para su uso" (published Jul 25, 2026), on Executive Decree 179 of 2018. Accessed Oct 16, 2026. ↩ ↩² ↩³ ↩⁴

7. https://ipscell.com/2021/02/fact-check-of-panama-stem-cell-institute-cost-safety-efficacy/ — Paul Knoepfler, The Niche, "Fact check of Panama Stem Cell Institute cost, safety, efficacy" (published Feb 18, 2021), quoting the clinic's website. Accessed Oct 16, 2026. ↩ ↩²

8. https://www.prensa.com/sociedad/minsa-abre-investigacion-a-locales-que-ofrecen-tratamientos-con-celulas-madre/ — La Prensa (Panama), "Minsa abre investigación a locales que ofrecen tratamientos con células madre" (published Aug 31, 2026). Accessed Oct 16, 2026. ↩

9. https://pmc.ncbi.nlm.nih.gov/articles/PMC10031296/ — Ikka T., Fujita M. et al., Stem Cell Reports, "Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan" (published Feb 23, 2023). Accessed Oct 16, 2026. ↩ ↩² ↩³

10. https://saiseiiryo.mhlw.go.jp/ — Ministry of Health, Labour and Welfare (Japan), "e-再生医療" (e-Regenerative Medicine) plan disclosure site. Accessed Oct 16, 2026. ↩

11. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes — US Food and Drug Administration, "Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes" (content current as of Apr 9, 2024). Accessed Oct 16, 2026. ↩ ↩²

12. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-remestemcel-l-rknd-steroid-refractory-acute-graft-versus-host-disease-pediatric — US Food and Drug Administration, "FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients" (published Dec 18, 2024). Accessed Oct 16, 2026. ↩

Show all 12 sources